SMA Newsroom

NewslettersTreatmentsJun 4, 2025

Community Update Roche: EMA approval of the risdiplam tablet

We are pleased to share a community letter from Roche, announcing that the European Commission (EC) has approved a new, room- temperature stable tablet formulation of risdiplam. 

New publication: Spinal cord stimulation: A new perspective for SMA research by Rare Revolution Magazine.

We are delighted to invite you to read the latest Spinal cord stimulation: A new perspective for SMA research by Rare Revolution Magazine.